This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for Trazimera® (trastuzumab)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for UK

Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for UK

PP-TAS-GBR-0064 January 2025